Table 4.
Imaging modalities obtained at baseline in trial patients (required imaging indicated with an asterisk*). The last column indicates the total number of imaging studies available for pooling.
| Modality | MR CLEAN |
EXTEND-IA | ESCAPE | SWIFT PRIME |
REVASCAT | THERAPY | Total |
|---|---|---|---|---|---|---|---|
| Noncontrast CT (NCCT) | 499/500 (99.8%)* |
70/70 (100%)* |
313/315 (99.4%)* |
163/195 (83.6%)* |
206/206 (100%)* |
108/108 (100%)* |
1,359 |
| Perfusion CT (PCT) | 333/500 (66.6%) 175/500 (35%) available |
70/70 (100%)* |
138/315 (43.8%) |
139/195 (71.2%) |
64/206 (31.1%) |
40/108 (37.0%) |
784 |
| CT Angiography (CTA) | 496/500 (99.2%)* |
70/70 (100%)* |
313/315 (99.4%)* |
159/195 (81.5%)* |
195/206 (94.7%)* |
99/108 (91.7%)* |
1,332 |
| Diffusion-Weighted MR Imaging (DWI) | 19/500 (3.8%) |
none | 2 /315 (0.006%) |
34/195 (17.4%)* |
11/206 (5.3%)* |
3/108 (2.8%) |
69 |
| Perfusion-Weighted MR Imaging (PWI) | none | none | none | 34/195 (17.4%)* |
5/206 (2.4%) |
1/108 (0.9%) |
40 |
| MR Angiography (MRA) | 2/500 (0.4%) |
none | 2 /315 (0.006%) |
32/195 (16.4%)* |
11/206 (5.3%)* |
2/108 (1.9%) |
49 |